The Dental Innovation Alliance (DIA), an investment firm consisting of dental industry executives, has announced its investment in the Swiss startup Odne (former Lumendo). This investment serves as a recognition for Odne’s innovative solutions in dental health, coming just shortly after the FDA approval for their products, OdneFill and OdneCure, and will help facilitate Odne’s U.S. launch.
Root canal treatments have long posed challenges for dentists, with traditionally low success rates ranging from 46% to 91%. With over 60 million annual treatments worldwide, these failures result in significant healthcare costs. Dübendorf-based startup Odne develops innovative root canal treatments that reduce the need for bleach and allow for faster treatment in endodontic therapy. Their first light-curing endodontic filler, OdneFill, as well as their laser-based dental curing light, OdneCure, have recently received FDA clearance, paving the way for their market entry in the U.S.
In January, the Dental Innovation Alliance (DIA), a network of dental industry experts, recognized Odne’s advancements in dental treatment with an investment – details of the transactions were not disclosed. Their investor base includes executives and experts from some of the largest and most innovative dental support organizations, which are poised to be early adopters of Odne's latest product set to launch in Q1 2024.
Andreas Schmocker, Odne’s CEO, commented: “We are thrilled to access DIA's network. I'm confident that their collective knowledge and expertise will uniquely help our company expand launch in the United States. DIA is committed to supporting innovation that leads to improved practice efficiencies and better clinical results helping providers and patients. At Odne, we develop products that do exactly that. We are honored that Odne is the DIA's latest investment.”
(Press release / SR)
Please login or sign up to comment.
Commenting guidelines